Comments
Lilly drug chosen for U.S.-sponsored Alzheimer's trial
19.01.2013. | (Reuters) - Researchers have selected Eli Lilly and Co's experimental treatment, solanezumab, for a federally sponsored study of whether Alzheimer's disease can be slowed or prevented in older patients who have not yet developed significant memory problems....
